| Year |
Citation |
Score |
| 2008 |
DiPaola RS, Dvorzhinski D, Thalasila A, Garikapaty V, Doram D, May M, Bray K, Mathew R, Beaudoin B, Karp C, Stein M, Foran DJ, White E. Therapeutic starvation and autophagy in prostate cancer: a new paradigm for targeting metabolism in cancer therapy. The Prostate. 68: 1743-52. PMID 18767033 DOI: 10.1002/Pros.20837 |
0.463 |
|
| 2007 |
Ashok BT, Tadi K, Garikapaty VP, Chen Y, Huang Q, Banerjee D, Konopa J, Tiwari RK. Preclinical toxicological examination of a putative prostate cancer-specific 4-methyl-1-nitroacridine derivative in rodents. Anti-Cancer Drugs. 18: 87-94. PMID 17159506 DOI: 10.1097/01.Cad.0000236316.04199.20 |
0.543 |
|
| 2006 |
Garikapaty VP, Ashok BT, Tadi K, Mittelman A, Tiwari RK. 3,3'-Diindolylmethane downregulates pro-survival pathway in hormone independent prostate cancer. Biochemical and Biophysical Research Communications. 340: 718-25. PMID 16380095 DOI: 10.1016/J.Bbrc.2005.12.059 |
0.617 |
|
| 2006 |
Garikapaty VP, Ashok BT, Tadi K, Mittelman A, Tiwari RK. Synthetic dimer of indole-3-carbinol: second generation diet derived anti-cancer agent in hormone sensitive prostate cancer. The Prostate. 66: 453-62. PMID 16353249 DOI: 10.1002/Pros.20350 |
0.617 |
|
| 2005 |
Dipaola RS, Dvorzhinski D, Nelson D, Garikapaty V, White E. 2-deoxyglucose (2DG) bypasses Bcl-2 and Akt mediated resistance in prostate cells. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 9535. PMID 27946760 DOI: 10.1200/Jco.2005.23.16_Suppl.9535 |
0.391 |
|
| 2005 |
Stein MN, Todd MB, Morton RA, Doyle-Lindrud S, Goodin S, Shah A, Shih W, Garikapaty V, Dvorzhinski D, Dipaola RS. A completed phase I trial of 13-cis retinoic acid, alpha interferon, docetaxel, and estramustine (R.I.T.E.) for the treatment of hormone refractory prostate cancer (HRPC) and other advanced malignancies and effect on BCL-2 expression. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 4740. PMID 27943954 DOI: 10.1200/Jco.2005.23.16_Suppl.4740 |
0.314 |
|
| 2005 |
Garikapaty VP, Ashok BT, Chen YG, Mittelman A, Iatropoulos M, Tiwari RK. Anti-carcinogenic and anti-metastatic properties of indole-3-carbinol in prostate cancer. Oncology Reports. 13: 89-93. PMID 15583807 DOI: 10.3892/Or.13.1.89 |
0.606 |
|
| 2003 |
Chen YG, Ashok BT, Liu X, Garikapaty VP, Mittelman A, Tiwari RK. Induction of heat shock protein gp96 by immune cytokines. Cell Stress & Chaperones. 8: 242-8. PMID 14984057 DOI: 10.1379/1466-1268(2003)008<0242:Iohspg>2.0.Co;2 |
0.459 |
|
| 2003 |
Ashok BT, David L, Chen YG, Garikapaty VP, Chander B, Kanduc D, Mittelman A, Tiwari RK. Peptide mimotopes of oncoproteins as therapeutic agents in breast cancer. International Journal of Molecular Medicine. 11: 465-71. PMID 12632099 DOI: 10.3892/Ijmm.11.4.465 |
0.465 |
|
| 2002 |
Ashok BT, Chen YG, Liu X, Garikapaty VP, Seplowitz R, Tschorn J, Roy K, Mittelman A, Tiwari RK. Multiple molecular targets of indole-3-carbinol, a chemopreventive anti-estrogen in breast cancer. European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 11: S86-93. PMID 12570340 |
0.53 |
|
| 1999 |
Tiwari RK, Geliebter J, Garikapaty VP, Yedavelli SP, Chen S, Mittelman A. Anti-tumor effects of PC-SPES, an herbal formulation in prostate cancer. International Journal of Oncology. 14: 713-9. PMID 10087319 DOI: 10.3892/Ijo.14.4.713 |
0.57 |
|
| Show low-probability matches. |